Kidney International Reports (May 2025)

Uncovering the Link Between Kynurenic Acid Pathway and Kidney Failure

  • Carolla El Chamieh,
  • Sophie Liabeuf,
  • Islam Amine Larabi,
  • Natalia Alencar De Pinho,
  • Margaux Costes-Albrespic,
  • Luc Frimat,
  • Céline Lange,
  • Yves-Édouard Herpe,
  • Jean-Charles Martin,
  • Pierre Letourneau,
  • Benoit Bérengère,
  • Christophe Soulage,
  • Stéphane Burtey,
  • Jean-Claude Alvarez,
  • Laetitia Koppe,
  • Ziad A. Massy,
  • Prs T. Hannedouche,
  • B. Moulin,
  • Dr A. Klein,
  • Pr C. Combe,
  • Dr J.P. Bourdenx,
  • Dr A. Keller,
  • Dr C. Delclaux,
  • Dr B. Vendrely,
  • Dr B. Deroure,
  • Dr A. Lacraz,
  • Dr T. Lobbedez,
  • Dr I. Landru,
  • Pr Z. Massy,
  • Pr P. Lang,
  • Dr X. Belenfant,
  • Pr E. Thervet,
  • Dr P. Urena,
  • Dr M. Delahousse,
  • Dr C. Vela,
  • Pr M. Essig,
  • Dr D. Clément,
  • Dr H. Sekhri,
  • Dr M. Smati,
  • Dr M. Jamali,
  • Dr B. Hacq,
  • Dr V. Panescu,
  • Dr M. Bellou,
  • Pr Luc Frimat,
  • Pr N. Kamar,
  • Prs C. Noël et F. Glowacki,
  • Dr N. Maisonneuve,
  • Dr R. Azar,
  • Dr M. Hoffmann,
  • Pr M. Hourmant,
  • Dr A. Testa,
  • Dr D. Besnier,
  • Pr G. Choukroun,
  • Dr G. Lambrey,
  • Pr S. Burtey,
  • Dr G. Lebrun,
  • Dr E. Magnant,
  • Pr M. Laville,
  • Pr D. Fouque,
  • L. Juillard,
  • Dr C. Chazot,
  • Pr P. Zaoui,
  • Dr F. Kuentz

DOI
https://doi.org/10.1016/j.ekir.2025.02.024
Journal volume & issue
Vol. 10, no. 5
pp. 1404 – 1414

Abstract

Read online

Introduction: Recent studies have focused on some uremic toxins, particularly those derived from tryptophan, as potential modifiable risk factors of chronic kidney disease (CKD) progression. The kynurenine pathway is the major enzymatic pathway for sequentially catabolizing tryptophan, resulting in key metabolites including kynurenine and kynurenic acid (KA) by the aminoadipate aminotransferase. We aimed at evaluating the association of serum KA levels and KA-to-kynurenine ratio (as indicators of aminoadipate aminotransferase activity) with kidney failure. Methods: The Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) study is a prospective cohort of patients with CKD having an estimated glomerular filtration rate (eGFR) < 60 ml/min per 1.73 m2. Baseline samples of uremic toxins were measured using a validated liquid chromatography tandem mass spectrometry technique. Cause-specific Cox models were used to estimate hazard ratios (HRs) for our outcome. The kidney gene expression of the kynurenine pathway was evaluated in 5 or 6 nephrectomy CKD mice and adenine-diet CKD mice under nephroprotective low protein diet (5% w/w). Results: Over a median follow-up period of 5 years, 608 out of the 2406 patients progressed to kidney failure. A 2-fold increase in serum KA levels and KA-to-kynurenine ratio were respectively associated with a 22% and 20%-increase in the hazard of kidney failure after multiple adjustments. In the mouse model, positive correlation was found between aminoadipate aminotransferase expression and fibrosis-related genes and kidney fibrosis. A low-protein diet was associated with a decrease in aminoadipate aminotransferase expression in the kidney as well as in inflammatory and fibrosis markers. Conclusion: Our findings suggest that the kynurenine pathway is associated with kidney failure, and that the inhibition of aminoadipate aminotransferase and the subsequent reduction of KA accumulation is a promising target to mitigate kidney disease progression.

Keywords